A Review of Disease Mechanisms and Current and Emerging Treatment Options for Generalized Myasthenia Gravis
Patients with generalized myasthenia gravis (gMG) receive multiple immunosuppressive therapies, but with incomplete suppression of IgG autoantibodies. Review this update on gMG to learn about novel therapies that can more effectively suppress IgG autoantibodies through a novel mechanism of action to help your patients achieve better clinical outcomes.
- Myasthenia Gravis
- Webinar recorded
- AMA PRA Category 1 Credit™